Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07751172

EVALUATION OF ORTHOKERATOLOGY LENSES WITH A 5MM OPTIC ZONE DIAMETER

To evaluate the clinical performance and user-reported experience of Paragon CRT contact lenses with a 5mm Optic Zone Diameter (OZD)

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

7 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Complutense University of Madrid Av., Madrid, Moncloa - Aravaca,, Spain

Loading trial locations.

About this study

Prospective, multi-site, clinical study evaluating the first-fit success, visual performance, and ocular health outcomes of 5mm OZD orthokeratology lenses fit empirically.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

A person is eligible for inclusion in the study if they:

  • Are 6- 35 years of age
  • If under 18 years old they are accompanied by a parent or legal guardian who is able to read, understand and sign the parental information and permission document
  • Have had a self-reported visual exam in the last two years
  • Are able to read (or be read to), understand and sign the assent document if under 18 years old or are able to read, understand and sign the consent document if aged 18 or older
  • Are willing to comply with the wear schedule (approximately 8 hours per night for every night, while sleeping)
  • Are willing to comply with the visit schedule
  • Have a refractive spherical component of their prescription between -0.50 and up to -6.00 diopters (inclusive) AND a refractive cylinder of no more than -1.75 diopters
  • Have a refractive spherical component ≥ cylinder component
  • Have a minimum visual acuity of +0.20 logMAR with each eye, when refracted at the Screening visit
  • Have clear corneas and no active ocular disease.
  • Have no medication, medical condition, or ocular conditions that contraindicate contact lens wear OR are expected to affect lens comfort or vision across the 1-month study duration, in the opinion of the investigator
  • Can be shown to have stable keratometry for at least the previous 1 month, if they have previously worn orthokeratology lenses.

Exclusion criteria

  • Present at screening visit with the presence of ocular or systemic disease or report the use medications which might interfere with orthokeratology contact lens wear, such as keratoconus, diabetes mellitus, steroid eye drops
  • Have a post-treatment predicted flat K value ≤38.00D (e.g. Patient baseline flat keratometry value = 40.00, patient has 2.00D of myopic refractive error. 40.00-2.00= 38.00D)
  • Have a known sensitivity to the diagnostic sodium fluorescein to be used in the study
  • Are pregnant, planning a pregnancy or lactating
  • Have amblyopia
  • Have presbyopia or has dependence on spectacles for near work over the contact lenses
  • Present at screening visit with the presence of clinically significant (grade ≥3; ISO scale) anterior segment abnormalities.
  • Present at screening visit with slit lamp findings that would contraindicate orthokeratology contact lens wear such as:
  • Pathological dry eye or associated findings 2. Pterygium, pinguecula, or corneal scars within the visual axis 3. Neovascularization > 0.75 mm from of the limbus 4. Giant papillary conjunctivitis (GPC) worse than grade 1 5. Anterior uveitis or iritis (past or present) 6. Seborrheic eczema, Seborrheic conjunctivitis 7. History of corneal ulcers or fungal infections 8. Poor personal hygiene 9. Aphakia

Treatment and study plan

Lens A (paflufocon D)

Device

5 minutes of daily wear

Primary outcomes

  1. Comfort at 5 Minutes and 1 Month After Final Lens Dispense

    Time frame: 5 minutes after insertion

    To assess participant-reported comfort of empirically fitted orthokeratology contact lenses by comparing comfort scores measured 5 minutes after lens insertion at the final dispense visit with comfort scores reported after 1 month of lens wear. Comfort will be assessed using a 0 to 10 scale, where 0 indicates "painful" and 10 indicates "cannot feel the lenses

Study contacts

Contact information is provided by the study sponsor or research team.

Kelly Voltz

CONTACT

[email protected]

+19256604364

Sponsors and collaborators

Lead sponsor

CooperVision International Limited (CVIL)

Industry

Collaborators

  • CooperVision, Inc.

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 7, 2026
Registry last updated
Aug 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.